Alberto-Culver
This article was originally published in The Rose Sheet
Executive Summary
Beauty care manufacturer obtains three-year, $300 mil. revolving credit facility with Bank of America (administrative agent), Bank One, LaSalle Bank and Citibank, firm announces Sept. 10. Credit facility will be used for general corporate purposes, including possible acquisitions, although firm notes it has "no plans" to draw on facility in near future. Melrose Park, Ill. company recently noted its interest in acquisitions, citing one possibility worth more than $100 mil. (1"The Rose Sheet" April 29, 2002, p. 4). New credit arrangement replaces five-year, $250 mil. facility that expired Sept. 10...
You may also be interested in...
Alberto-Culver
Beauty care manufacturer extends its $300 mil. revolving credit agreement with group of banks from three to five years, firm announces Sept. 2. Agreement between Alberto and Bank of America, Citibank, Bank One, LaSalle Bank, William Street Commitment Corporation and Svenska Handelsbanken was signed Aug. 31. Company notes amended facility will be used for "general corporate purposes, including possible acquisitions," but added it has no plans to draw from it in the near future. Alberto obtained the $300 mil. facility in 2002 (1"The Rose Sheet" Sept. 16, 2002, In Brief)...
St. Ives Daily Cleansing Cloths Launching With TV, Print Ads
Alberto-Culver will promote the exfoliating benefits of its new St. Ives cleansing cloths as a point of difference with other facial cloths in the market, according to VP-Skin Care Jim Gonedes
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.